Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial Case Study Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…Certara2023 年 4 月 17 日
Using Real World Evidence to Inform Treatment Guidelines Case Study 运用真实世界证据指导治疗指南制定 Real-World Evidence (RWE) has become increasingly valuable in informing the development of treatment guidelines for…Certara2023 年 4 月 5 日
Using Real Word Evidence to Enhance Drug Development Case Study Using Real Word Evidence to Enhance Drug Development Real-world evidence (RWE) has emerged as an increasingly important tool in the drug development process,1…Certara2023 年 4 月 5 日
ISPOR International Annual Conference 2026 Conference ISPOR International Annual Conference 2026 –Certara2023 年 2 月 15 日
Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another Case Study 利用一种罕见病的临床数据支持另一种罕见病的药物审批 Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…Certara2022 年 6 月 1 日